on 10 Feb 2020
Last Applicant/ Owned by
2050 Cabot Blvd. West
Langhorne
PA
19047
Serial Number
88453270 filed on 30th May 2019
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"PHARMACEUTICALS"
Pharmaceutical preparations for the prevention of endometrial hyperplasia and the management of exogenous obesity The color(s) purple is/are claimed as a feature of the mark. "PHARMACEUTICALS" The mark consists of the purple stylized wordings "ACERTIS" above "PHARMACEUTICALS" all to the right of a triangle design displayed in various shades of purple and having a triangular center space. The whRead More
Pharmaceutical preparations for the prevention of endometrial hyperplasia and the management of exogenous obesity
No 88453270
No Service/Collective Mark
No 18061-1
No
No
No
No
No
No
No
No
26.05.21 -
Triangles that are completely or partially shaded
The mark consists of the purple stylized wordings "ACERTIS" above "PHARMACEUTICALS" all to the right of a triangle design displayed in various shades of purple and having a triangular center space. The white appearing in the mark represents background and is not claimed as a feature of the mark.
| Status Date | Action Taken |
|---|---|
| 10th Feb 2020 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| 10th Feb 2020 | ABANDONMENT - AFTER PUBLICATION |
| 05th Feb 2020 | TEAS EXPRESS ABANDONMENT RECEIVED |
| 08th Nov 2019 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 15th Oct 2019 | PUBLISHED FOR OPPOSITION |
| 15th Oct 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 25th Sep 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 09th Sep 2019 | ASSIGNED TO LIE |
| 05th Sep 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 04th Sep 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
